Nanjing CIGU Technology Corp.,LTD. (SHA:688448)

Market Cap	2.86B
Revenue (ttm)	472.77M
Net Income (ttm)	46.41M
Shares Out	71.50M
EPS (ttm)	0.65
PE Ratio	61.86
Forward PE	n/a
Dividend	0.30 (0.75%)
Ex-Dividend Date	Jun 18, 2025

Volume	13,572,042
Average Volume	2,977,639
Open	37.37
Previous Close	37.00
Day's Range	37.00 - 44.40
52-Week Range	15.04 - 49.88
Beta	0.11
RSI	89.29
Earnings Date	Aug 19, 2025

About Revance Therapeutics

Nanjing CIGU Technology Corp.,LTD. research, develops, produces, and sells drive equipment and integrated fluid mechanical equipment. The company offers centrifugal blowers, centrifugal air compressors, turbo expanders, centrifugal chillers, and vacuum pumps under the Maglev name, as well as software technical services. It also offers core components, such as high-speed motors and high-speed drives. The company was founded in 2006 and is based in Nanjing, China.

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• Founded: 2006
• Employees: 394
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688448

Financial Performance

In 2024, SHA:688448's revenue was 478.49 million, an increase of 15.70% compared to the previous year's 413.56 million. Earnings were 51.50 million, an increase of 7.15%.